# FDA 483 - George Timothy Kelly. M.D. - February 15, 2024

Source: https://www.globalkeysolutions.net/records/483/george-timothy-kelly-md/7f6c2d20-73f0-42be-a376-00c3fd43062c

> FDA 483 for George Timothy Kelly. M.D. on February 15, 2024. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: George Timothy Kelly. M.D.
- Inspection Date: 2024-02-15
- Product Type: drugs
- Office Name: Division of Human and Animal Food Operations - West V
- Summary: An FDA inspection of G. Timothy Kelly, M.D. in Las Vegas, NV, revealed significant deviations from study protocols and inadequate record-keeping for investigational products. Observations included failures in conducting required subject analyses and assessments, issues with eligibility determination, and poor investigational drug accountability. These findings indicate a lack of adherence to clinical investigation standards.

## Related Officers

- [investigator](https://www.globalkeysolutions.net/people/rebecca-t-davis/a821f7ef-0c73-4be1-9a9b-3fc2c07f88c1)

Company: https://www.globalkeysolutions.net/companies/george-timothy-kelly-md/a7403a7e-b313-4758-aa1e-27dab4febd00

Office: https://www.globalkeysolutions.net/offices/division-of-human-and-animal-food-operations-west-v/0f4dd01e-8e8a-4336-9abe-ce8b3d309e8b